Cases & Deals

CARMAT completes €50 million capital increase


Jones Day represented CARMAT SA, a designer and developer of the world's most advanced heart project, aiming to provide a therapeutic alternative for people suffering from end-stage biventricular heart failure, in connection with its €50 million (US$56.2 million) reserved capital increase between CARMAT, its core shareholders, and a pool of strategic investors including Airbus Group (Matra Défense), Truffle Capital, CorNovum (Bpifrance), ALIAD (Air Liquide), and the family offices of Mr. Pierre Bastid and Mr. Antonino Ligresti.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.